Coffee Consumption May Mitigate the Risk for Acute Kidney Injury: Results From the Atherosclerosis Risk in Communities Study

Coffee is one of the most frequently consumed beverages worldwide and has been found to have a wide assortment of health benefits. Although habitual coffee consumption is associated with a lower incidence of chronic kidney disease, an association between coffee and acute kidney injury (AKI) has not yet been revealed.MethodsIn the Atherosclerosis Risk in Communities… Continue reading Coffee Consumption May Mitigate the Risk for Acute Kidney Injury: Results From the Atherosclerosis Risk in Communities Study

1186-021 / 21 – REGULAR COFFEE INTAKE IS ASSOCIATED WITH IMPROVED MORTALITY IN PREVALENT CARDIOVASCULAR DISEASE

Historically physicians recommend avoiding coffee in patients with arrhythmia and cardiovascular disease (CVD). However, data is lacking on safety of coffee in those with prevalent arrhythmia/CVD. We sought to investigate the associations between coffee and mortality/arrhythmia outcomes in prevalent conditionsMethods: The UK Biobank consists of 502543 people followed over > 10years. Self-reported coffee intake was divided… Continue reading 1186-021 / 21 – REGULAR COFFEE INTAKE IS ASSOCIATED WITH IMPROVED MORTALITY IN PREVALENT CARDIOVASCULAR DISEASE

1052-05 – GROUND, INSTANT, OR DECAFFEINATED COFFEE? IMPACT OF DIFFERENT COFFEE SUBTYPES ON INCIDENT ARRHYTHMIA, CARDIOVASCULAR DISEASE AND MORTALITY

Background: Population studies report health benefits from coffee intake. Coffee has up to 100 biologic compounds with caffeine most well known. The effects of coffee subtypes on cardiovascular(CV) outcomes is unclear. We aim to evaluate the associations between coffee subtypes and incident arrhythmia, CV disease (CVD), and total/ CV mortalityMethods: Participant responses to coffee amount and type(ground,… Continue reading 1052-05 – GROUND, INSTANT, OR DECAFFEINATED COFFEE? IMPACT OF DIFFERENT COFFEE SUBTYPES ON INCIDENT ARRHYTHMIA, CARDIOVASCULAR DISEASE AND MORTALITY

1056-05 – EFFECTS OF HABITUAL COFFEE CONSUMPTION ON INCIDENT CARDIOVASCULAR DISEASE, ARRHYTHMIA, AND MORTALITY: FINDINGS FROM UK BIOBANK

Background: Meta analyses report beneficial effects of coffee intake on incident cardiovascular outcomes, however earlier studies are limited by smaller sample sizes. The aim was to evaluate associations between coffee intake and incident arrhythmia, CVD, and mortality, utilising the UK BiobankMethods: The UK Biobank is a large prospective cohort with outcomes measured >10 years. Coffee… Continue reading 1056-05 – EFFECTS OF HABITUAL COFFEE CONSUMPTION ON INCIDENT CARDIOVASCULAR DISEASE, ARRHYTHMIA, AND MORTALITY: FINDINGS FROM UK BIOBANK

Higher Coffee Consumption Is Associated With Slower Cognitive Decline and Less Cerebral Aβ-Amyloid Accumulation Over 126 Months: Data From the Australian Imaging, Biomarkers, and Lifestyle Study

Worldwide, coffee is one of the most popular beverages consumed. Several studies have suggested a protective role of coffee, including reduced risk of Alzheimer’s disease (AD). However, there is limited longitudinal data from cohorts of older adults reporting associations of coffee intake with cognitive decline, in distinct domains, and investigating the neuropathological mechanisms underpinning any… Continue reading Higher Coffee Consumption Is Associated With Slower Cognitive Decline and Less Cerebral Aβ-Amyloid Accumulation Over 126 Months: Data From the Australian Imaging, Biomarkers, and Lifestyle Study

Consumption of coffee and tea and risk of developing stroke, dementia, and poststroke dementia: A cohort study in the UK Biobank

Previous studies have revealed the involvement of coffee and tea in the development of stroke and dementia. However, little is known about the association between the combination of coffee and tea and the risk of stroke, dementia, and poststroke dementia. Therefore, we aimed to investigate the associations of coffee and tea separately and in combination… Continue reading Consumption of coffee and tea and risk of developing stroke, dementia, and poststroke dementia: A cohort study in the UK Biobank

All #coffee types decrease the risk of adverse clinical outcomes in chronic #liver disease: a UK Biobank study

Chronic liver disease (CLD) is a growing cause of morbidity and mortality worldwide, particularly in low to middle-income countries with high disease burden and limited treatment availability. Coffee consumption has been linked with lower rates of CLD, but little is known about the effects of different coffee types, which vary in chemical composition. This study… Continue reading All #coffee types decrease the risk of adverse clinical outcomes in chronic #liver disease: a UK Biobank study

#Cardiovascular symptoms affect the patterns of habitual #coffee consumption

Excessive coffee consumption can lead to unpleasant sensations such as tachycardia and heart palpitations. ObjectivesOur aim was to investigate if cardiovascular symptoms can lead to alterations in habitual patterns of coffee consumption. MethodsWe used information from up to 390,435 European ancestry participants in the UK Biobank, aged 39–73 y. Habitual coffee consumption was self-reported, and… Continue reading #Cardiovascular symptoms affect the patterns of habitual #coffee consumption

#Caffeine increases maximal #fat oxidation during a graded exercise test: is there a diurnal variation?

There is evidence that caffeine increases the maximal fat oxidation rate (MFO) and aerobic capacity, which are known to be lower in the morning than in the afternoon. This paper examines the effect of caffeine intake on the diurnal variation of MFO during a graded exercise test in active men. Methods Using a triple-blind, placebo-controlled,… Continue reading #Caffeine increases maximal #fat oxidation during a graded exercise test: is there a diurnal variation?